TRex Bio Statistics

NASDAQ: TRXBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

14.03+0.03 (+0.21%)

At close: Oct 12, 4:00 PM ET · Delayed 15 min

After hours: 13.99 -0.29%

TRex Bio by the numbers

TRex Bio has a market capitalization of $385.1 million based on 27.45M shares outstanding. With trailing EPS of $-2.47, TRex Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.2% above its 50-day average and 0.2% above its 200-day average.

Average daily trading volume is 1.26M shares, or about $17.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

TRXB valuation vs. peer median

TRXB compared with the median of 8 peer companies
Metric	TRXB	Peer median	Difference
Market cap	$385.06M	$383.68M	+0%
Avg. volume	1.26M	1.16M	+8%

Peer median across 8 companies: KYTX, ZURA, SCTX, CCCC, FENC, EIKN, EDIT, AGEN.

Valuation

Market cap: $385.06M
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-2.47
Shares outstanding: 27.45M

Price and trading

Previous close: 14.00
Open: 14.19
Day range: 13.75 – 14.36
52-week range: 13.50 – 15.50
50-day moving average: 14.00
200-day moving average: 14.00
Beta: —
Volume: 188.96K
Average volume: 1.26M

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: —

Additional statistics

Market Cap: 385.06M
Eps: -2.47
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 15.50
Week52 Low: 13.50
Avg Volume: 1.26M
Shares Outstanding: 27.45M
Ma50: 14.00
Ma200: 14.00
Pct From52w High: -9.48%
Pct From52w Low: 3.93%